Harnessing microRNA biology to treat
    cardiovascular and muscle disease
Sunday February 05, 2012
 
Partnerships

Collaboration is essential to effective drug discovery and development.

At miRagen, we seek to create long-term partnerships and strategic alliances with each of the following:

  • Academic institutions involved in ground-breaking research;
  • Companies with innovative, complementary technologies that build on or enhance our programs; and
  • Pharmaceutical development partners.

Leveraging distinct core competencies is essential to delivering new and innovative microRNA-based therapeutics to patients around the world.

miRagen is committed to our mission of creating life-changing microRNA-based therapeutics. We are dedicated to forming strategic alliances to fully exploit the potential of our product pipeline, as well as to in-licensing best-in-class discoveries related to microRNA therapeutics, nucleic acid chemistries and delivery technologies.

 

Thank you for for your interest in miRagen Therapeutics. For more information, please contact us at BD@miragenrx.com.